Detalhe da pesquisa
1.
Publisher Correction: BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design.
Nat Chem Biol
; 15(8): 846, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31267096
2.
BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design.
Nat Chem Biol
; 15(7): 672-680, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31178587
3.
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition.
Nat Chem Biol
; 12(9): 672-9, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27376689
4.
Highly Selective PTK2 Proteolysis Targeting Chimeras to Probe Focal Adhesion Kinase Scaffolding Functions.
J Med Chem
; 62(5): 2508-2520, 2019 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30739444
5.
Chemically Induced Degradation of the Oncogenic Transcription Factor BCL6.
Cell Rep
; 20(12): 2860-2875, 2017 Sep 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28930682
6.
A Novel RAF Kinase Inhibitor with DFG-Out-Binding Mode: High Efficacy in BRAF-Mutant Tumor Xenograft Models in the Absence of Normal Tissue Hyperproliferation.
Mol Cancer Ther
; 15(3): 354-65, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26916115
7.
Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor.
J Med Chem
; 59(10): 4462-75, 2016 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-26914985